Schering-Plough to seek more opportunities abroad

04/23/2008 | Bloomberg1

Schering-Plough Corp. plans to expand its business overseas as government pressures and negative news coverage of its studies on cholesterol drug Vytorin pull down U.S. sales, CEO Fred Hassan said. The drugmaker has been entering markets that the industry generally ignores because "half-a-billion people are moving into the middle class," Hassan said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC